Stockscreener 앱 받기
104.20
0.34%
-0.4699
전일 마감가:
$104.67
열려 있는:
$104.41
하루 거래량:
70,374
Relative Volume:
0.07
시가총액:
$4.83B
수익:
-
순이익/손실:
$-63.78M
주가수익비율:
-38.88
EPS:
-2.68
순현금흐름:
$-53.91M
1주 성능:
+3.74%
1개월 성능:
+1.55%
6개월 성능:
+672.09%
1년 성능:
+721.34%
1일 변동 폭
$103.47
$105.29
1주일 범위
$98.50
$112.00
52주 변동 폭
$7.575
$112.64
Celcuity Inc Stock (CELC) Company Profile
명칭
Celcuity Inc
전화
763-392-0767
주소
16305 36TH AVENUE N, MINNEAPOLIS, MN
CELC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CELC
Celcuity Inc
|
104.42 | 4.84B | 0 | -63.78M | -53.91M | -2.68 |
|
VRTX
Vertex Pharmaceuticals Inc
|
467.92 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
804.26 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.13 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
807.86 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
339.51 | 35.45B | 4.98B | 69.59M | 525.67M | 0.5197 |
Celcuity Inc Stock (CELC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-12 | 개시 | Wells Fargo | Overweight |
| 2025-11-18 | 개시 | Wolfe Research | Outperform |
| 2025-11-17 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-09-22 | 개시 | Guggenheim | Buy |
| 2025-07-01 | 재개 | Stifel | Buy |
| 2024-07-22 | 개시 | Leerink Partners | Outperform |
| 2024-02-22 | 개시 | Stifel | Buy |
| 2023-12-08 | 개시 | H.C. Wainwright | Buy |
| 2021-10-08 | 개시 | Canaccord Genuity | Buy |
| 2021-09-07 | 개시 | Jefferies | Buy |
| 2021-07-29 | 개시 | Cowen | Outperform |
| 2021-07-27 | 개시 | Needham | Buy |
| 2021-01-28 | 재확인 | H.C. Wainwright | Buy |
| 2020-12-24 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-11 | 재개 | Craig Hallum | Buy |
| 2018-11-20 | 개시 | H.C. Wainwright | Buy |
모두보기
Celcuity Inc 주식(CELC)의 최신 뉴스
Can Celcuity Inc. stock beat analyst upgradesJuly 2025 Review & Precise Swing Trade Entry Alerts - ulpravda.ru
The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech - GlobeNewswire
Is Celcuity Inc. stock attractive after correction2025 Trading Volume Trends & AI Powered Buy and Sell Recommendations - ulpravda.ru
Gains Recap: Can Celcuity Inc stock sustain free cash flow growthMarket Sentiment Review & AI Enhanced Market Trend Forecasts - moha.gov.vn
What valuation multiples suggest for Celcuity Inc. stockMean Reversion Trades & Exceptional Profit Growth - ulpravda.ru
Celcuity initiated with an Outperform at Wolfe Research - MSN
Celcuity Stock Up 677% in 6 Months: What's Behind This Huge Increase? - The Globe and Mail
Analysts Expect Breakeven For Celcuity Inc. (NASDAQ:CELC) Before Long - 富途牛牛
Celcuity (CELC) surges 662% in 2025 on breast cancer treatment trial results - MSN
What analysts say about Celcuity Inc stockWeekly Market Snapshot & You’ll Thank Yourself in 6 Months - earlytimes.in
Celcuity (CELC) Surges 662% in 2025 on Breast Cancer Treatment Trial Results - Insider Monkey
Meet the 10 Market Stars Behind Millionaire-Making in 2025 - Insider Monkey
2025’s best-performing Minnesota public company stock is a biopharmaceutical firm with no revenue - Star Tribune
Celcuity, Inc. (NASDAQ:CELC) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Trading Systems Reacting to (CELC) Volatility - Stock Traders Daily
Celcuity: After Stellar 2025, I Predict More Success In 2026 And Beyond (NASDAQ:CELC) - Seeking Alpha
Celcuity (CELC)’s Clinical Success and M&A Potential Underpin Wolfe Research’s Bullish View - MSN
Celcuity Inc. Earnings Call: Strong Progress Amid Challenges - MSN
Net current asset value per share of Celcuity Inc. – GETTEX:7VR - TradingView — Track All Markets
ETFs Investing in Celcuity Inc. Stocks - TradingView — Track All Markets
Top Biotech Stocks To Add to Your WatchlistDecember 20th - MarketBeat
Does Celcuity Inc. stock trade at a discount to peersJuly 2025 Short Interest & Risk Managed Investment Signals - Улправда
Celcuity (CELC): Reassessing Valuation After New VIKTORIA-1 Breast Cancer Data Boosts Investor Interest - Sahm
Rate Hike: Why Celcuity Inc. stock could be next big winnerMarket Growth Report & Advanced Technical Analysis Signals - Улправда
How Celcuity Inc. stock reacts to job market dataBear Alert & AI Enhanced Trading Alerts - ulpravda.ru
Why Celcuity Inc. stock is trending among retail traders2025 Valuation Update & Scalable Portfolio Growth Ideas - ulpravda.ru
Aug Retail: How Celcuity Inc. stock reacts to job market dataJuly 2025 Big Picture & Entry Point Strategy Guides - Улправда
(CELC) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
Will Celcuity Inc. stock deliver better than expected guidanceIPO Watch & Stepwise Trade Execution Plans - Bölüm Sonu Canavarı
Why Celcuity Inc. stock is a value investor pickJuly 2025 Opening Moves & Risk Managed Investment Strategies - DonanımHaber
How interest rate cuts could boost Celcuity Inc. stockMarket Weekly Review & Growth Focused Stock Reports - DonanımHaber
Rate Cut: Why Celcuity Inc. stock could be next big winnerJuly 2025 Big Picture & AI Powered Market Trend Analysis - Улправда
Why Celcuity Inc. stock is rated strong buyTrade Performance Summary & Risk Managed Investment Entry Signals - ulpravda.ru
Aug Final Week: Why Celcuity Inc. stock could be next big winnerWeekly Trade Report & Free Low Drawdown Momentum Trade Ideas - ulpravda.ru
Fundamentals Check: Does Celcuity Inc. stock trade at a discount to peersMarket Sentiment Summary & Weekly Top Gainers Alerts - Улправда
Why Celcuity Inc. stock could be next big winnerMarket Sentiment Report & Fast Gaining Stock Reports - Улправда
Aug Sectors: How Celcuity Inc. stock reacts to job market dataJuly 2025 Analyst Calls & Long-Term Capital Growth Ideas - Улправда
How Investors Are Reacting To Celcuity (CELC) Gedatolisib’s Phase 3 Breast Cancer Data And Safety Profile - Yahoo Finance
Leerink Partners raises Celcuity stock price target to $118 on gedatolisib outlook - Investing.com Nigeria
Leerink Partners raises Celcuity stock price target to $118 on gedatolisib outlook By Investing.com - Investing.com South Africa
Celcuity (CELC): Fresh Phase 3 Breast Cancer Data Prompts Closer Look at Gedatolisib-Driven Valuation - Yahoo Finance
Did Gedatolisib’s Phase 3 PFS and Tolerability Data Just Shift Celcuity’s (CELC) Investment Narrative? - simplywall.st
Celcuity (NASDAQ:CELC) Coverage Initiated by Analysts at Wells Fargo & Company - MarketBeat
Celcuity initiated with an overweight at Wells Fargo - MSN
Celcuity (CELC) Valuation Check After Paradigm-Shifting VIKTORIA-1 Breast Cancer Data Update - Sahm
Celcuity (NASDAQ:CELC) Hits New 1-Year HighShould You Buy? - MarketBeat
Eventide Asset Management LLC Buys 123,774 Shares of Celcuity, Inc. $CELC - MarketBeat
Wells Fargo Initiates Coverage of Celcuity (CELC) with Overweight Recommendation - Nasdaq
Is CELC Stock Overpriced? - timothysykes.com
RH Posts Strong Q3 Sales, Joins Canopy Growth, Tilray Brands, Frequency Electronics And Other Big Stocks Moving Higher On Friday - Benzinga
Celcuity stock hits all-time high at 109.15 USD By Investing.com - Investing.com Canada
Celcuity Inc (CELC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.59%
자본화:
|
볼륨(24시간):